These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32631802)

  • 21. Levosimendan: a new option in acute septic cardiac failure?
    Powell BP; De Keulenaer B
    Emerg Med Australas; 2007 Apr; 19(2):177; author reply 177-8. PubMed ID: 17448109
    [No Abstract]   [Full Text] [Related]  

  • 22. Levosimendan in heart failure after surgical repair of cardiac rupture.
    Torrado H; Ventura JL; Ruiz-Majoral A; Farrero E; Rodriguez-Castro D; Carrio ML; Miralles A
    Minerva Cardioangiol; 2009 Feb; 57(1):137-8. PubMed ID: 19202525
    [No Abstract]   [Full Text] [Related]  

  • 23. Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.
    Farmakis D; Alvarez J; Gal TB; Brito D; Fedele F; Fonseca C; Gordon AC; Gotsman I; Grossini E; Guarracino F; Harjola VP; Hellman Y; Heunks L; Ivancan V; Karavidas A; Kivikko M; Lomivorotov V; Longrois D; Masip J; Metra M; Morelli A; Nikolaou M; Papp Z; Parkhomenko A; Poelzl G; Pollesello P; Ravn HB; Rex S; Riha H; Ricksten SE; Schwinger RHG; Vrtovec B; Yilmaz MB; Zielinska M; Parissis J
    Int J Cardiol; 2016 Nov; 222():303-312. PubMed ID: 27498374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of outpatient administration of levosimendan in reducing hospital readmission in patients with heart failure.
    Acosta-Armas P; Medina-Gil JM; Martínez-Quintana E
    Med Clin (Barc); 2023 Nov; 161(9):403-404. PubMed ID: 37598053
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
    Udvary E; Papp JG; Végh A
    Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
    Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
    Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levosimendan: a new option in acute cardiac failure.
    Holley AD; Ziegenfuss M
    Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
    [No Abstract]   [Full Text] [Related]  

  • 28. Levosimendan: perpetuum mobile?
    Agewall S; Atar D
    Eur Heart J; 2007 Feb; 28(4):515. PubMed ID: 17283001
    [No Abstract]   [Full Text] [Related]  

  • 29. Levosimendan and quality of life.
    Papadopoulos CE; Zioutas DG; Dalamaga EG
    Hellenic J Cardiol; 2010; 51(1):81-2. PubMed ID: 20118051
    [No Abstract]   [Full Text] [Related]  

  • 30. Levosimendan: a novel agent in heart failure.
    Koumallos N; Antoniades C; Tousoulis D; Shirodaria C; Stefanadis C
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):185-91. PubMed ID: 18221085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [LEVOSIMENDAN--THE FIRST 10 YEARS IN CLINICAL PRACTICE].
    Rybka MM; Lobacheva GV
    Anesteziol Reanimatol; 2015; 60(5):80-4. PubMed ID: 26852586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical support and surgery of the failing heart: levosimendan.
    Toller W; Knez I
    Scand J Surg; 2007; 96(2):121-4. PubMed ID: 17679353
    [No Abstract]   [Full Text] [Related]  

  • 33. Levosimendan: a new era for inodilator therapy for heart failure?
    Cleland JG; McGowan J
    Curr Opin Cardiol; 2002 May; 17(3):257-65. PubMed ID: 12015475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan in end-stage heart failure.
    Yeo PSD
    JACC Heart Fail; 2013 Aug; 1(4):365. PubMed ID: 24621941
    [No Abstract]   [Full Text] [Related]  

  • 35. Levosimendan.
    Kamath SR; Jaykumar I; Matha S
    Indian Pediatr; 2009 Jul; 46(7):593-6. PubMed ID: 19638658
    [No Abstract]   [Full Text] [Related]  

  • 36. Patients with advanced heart failure and the effects of levosimendan.
    Song ZZ; Ma J
    Am J Cardiol; 2007 Aug; 100(4):742; author reply 742-3. PubMed ID: 17697841
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is there a role for levosimendan in hospital emergency departments?].
    Manzano-Fernández S; Marín F; Garrido Bravo IP; Pascual Figal DA
    Rev Esp Cardiol; 2008 May; 61(5):545-6; author reply 546. PubMed ID: 18462660
    [No Abstract]   [Full Text] [Related]  

  • 38. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of acute neurohormonal response after levosimendan treatment.
    Giannakoulas G; Giannoglou G; Vassilikos V; Martiadou K; Kalpidis P; Parharidis G; Louridas G
    Am J Cardiol; 2006 Oct; 98(8):1123-4. PubMed ID: 17027590
    [No Abstract]   [Full Text] [Related]  

  • 40. Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients.
    Parissis JT; Farmakis D; Bistola V; Adamopoulos S; Kremastinos DT
    Am J Cardiol; 2007 Jan; 99(1):146-7. PubMed ID: 17196480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.